
The Biden Administration Is Letting Big Pharma Profiteer Off a Cancer Drug
Under existing law, Joe Biden and his health secretary have the power to lower the price of medicines developed with taxpayer funds. They’re refusing to do so for the $180,000-a-year cancer drug Xtandi — after a furious lobbying campaign by Big Pharma.